Moderna to cut $1.1 billion in costs and launch 10 new products by 2027 as it charts post-Covid path
CNBCModerna is deprioritizing certain parts of its pipeline, which involves pausing work on some products and scrapping others.
Moderna is deprioritizing certain parts of its pipeline, which involves pausing work on some products and scrapping others.